Skip to Content

Cancer Imaging Program

  1. Contact Us

Programs & Resources

Presentations from the Sixth National Forum on Biomedical Imaging in Oncology

April 7-8, 2005
Hyatt Regency Bethesda
Bethesda, Maryland

Presented by:
The National Cancer Institute (NCI)
Food and Drug Administration (FDA)
Centers for Medicare and Medicaid Services (CMS)
National Electrical Manufacturers Association (NEMA)

The focus of the Sixth National Forum on Biomedical Imaging in Oncology was on Quantitative Oncologic Imaging. The meeting opened with updates from NEMA, the U.S. Food and Drug Administration (FDA), and Center for Medicare and Medicaid Services (CMS), summarizing progress made on issues raised at the 2004 Forum. Also in the opening session, the NCI updated on the review of the clinical trials process and current imaging activities.

The afternoon session on the first day included a keynote presentation on the critical need for quantitative oncologic imaging, then proceeded with presentations on tumor response criteria, imaging in clinical trials of cancer therapeutic agents, biological issues in quantitative oncologic imaging, high sensitivity and specificity agents, and detection devices.

Panel discussions were held following the morning and afternoon sessions.

Meeting Program and Presentations:

April 7

TimeTopicSpeaker
8:30 amWelcome and Opening RemarksDaniel Sullivan, MD
8:45 amWelcome from the National Electrical Manufacturers Association (NEMA)Thomas McCausland
9:00 amWelcome from NCI/DCTD and Update on NCI Review of Clinical Trials ProcessJames Doroshow, Ph.D.
9:15 amUpdate on NCI Imaging ActivitiesDaniel Sullivan, MD
9:40 amUpdate from FDA/Center for Devices and Radiological HealthDaniel Schultz, MD
10:30 amUpdate from FDA/Center for Drug Evaluation and ResearchJanet Woodcock, MD
10:50 amUpdate from Center for Medicare and Medicaid Services (CMS)Stephen Phurrough, MD, MPA
11:10 amPanel DiscussionSullivan, McCausland, Doroshow, Schultz, Woodcock, Phurrough, George Mills
1:00 pmKeynote Address: The Need for Quantitative Imaging in OncologyRichard Schilsky, MD
1:45 pmTumor Response Criteria: Anatomic (RECIST) & Functional ApproachesLarry Schwartz, MD
2:15 pmImaging Trials of Cancer Therapeutic Agents: Pharmaceutical PerspectiveSusan Galbraith, MD, PhD
3:15 pmBiological Issues in Oncology ImagingRoy Herbst, MD, PhD
3:45 pmDevelopment of High Sensitivity & Specificity Imaging Agents: Challenges & OpportunitiesMichael Tweedle, PhD
4:15 pmDetection Device/Acquisition IssuesKyle Myers, PhD
4:45 pmPanel DiscussionSchilsky, Schwartz, Galbraith, Herbst, Tweedle, Myers, Paula Jacobs, PhD

April 8

TimeTopicSpeaker
8:00 amThe Forefront in Imaging Processing: Anatomic/Physiologic ApproachesRichard Robb, PhD
8:35 amThe Forefront in Imaging Processing: PET/Molecular ApproachesJoel Karp, PhD
9:10 amBuilding Large Publicly-Available Image ArchivesLarry Clarke, PhD
10:00 amStandardizing Image AcquisitionJeff Evelhoch, PhD
10:30 amThe Data Explosion: How Can We Achieve Inter-operability?
Moderator: Larry Clarke, PhD
James Williams, PhD
F David Rollo, MD, PhD
Wesley Turner, PhD
11:30 amPanel DiscussionRobb, Karp, Clarke, Evelhoch, Williams, Rollo, Turner

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®